Scott Cormack
2008
In 2008, Scott Cormack earned a total compensation of $476.4K as President and Chief Executive Officer at OncoGenex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $183,875 |
|---|---|
| Option Awards | $194,674 |
| Salary | $97,874 |
| Total | $476,423 |
Cormack received $194.7K in option awards, accounting for 41% of the total pay in 2008.
Cormack also received $183.9K in non-equity incentive plan and $97.9K in salary.
Rankings
In 2008, Scott Cormack's compensation ranked 6,669th out of 9,135 executives tracked by ExecPay. In other words, Cormack earned more than 27.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,669 out of 9,135 | 27th |
Division Manufacturing | 2,479 out of 3,436 | 28th |
Major group Chemicals And Allied Products | 555 out of 815 | 32nd |
Industry group Drugs | 385 out of 597 | 36th |
Industry In Vitro and In Vivo Diagnostic Substances | 31 out of 51 | 39th |
Source: SEC filing on April 21, 2011.
Cormack's colleagues
We found four more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2008.